Endophthalmitis after pars plana vitrectomy: Incidence, causative organisms, and visual acuity outcomes

Am J Ophthalmol. 2004 Nov;138(5):799-802. doi: 10.1016/j.ajo.2004.06.035.

Abstract

Purpose: To investigate the incidence, causative organisms, and visual acuity outcomes associated with endophthalmitis after pars plana vitrectomy.

Design: Retrospective, noncomparative, consecutive case series.

Methods: The medical records were reviewed of all patients who developed acute-onset postoperative endophthalmitis (within 6 weeks of surgery) after pars plana vitrectomy at Bascom Palmer Eye Institute between January 1, 1984 and December 31, 2003.

Results: During the 20-year study interval, the overall incidence rate of postvitrectomy endophthalmitis was 0.039% (6/15,326). Cultured organisms were Staphylococcus aureus (n = 3), Proteus mirabilus (n = 1), and Staphylococcus epidermidis/Pseudomonas aeruginosa (n = 1); one case was culture-negative. Visual acuity after treatment for endophthalmitis ranged from 2/200 to no light perception, with a final vision of light perception or no light perception in four of six (67%) eyes.

Conclusion: The incidence of endophthalmitis after pars plana vitrectomy is low but the visual acuity outcomes after treatment are generally poor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Anterior Chamber / microbiology
  • Anti-Bacterial Agents
  • Drug Therapy, Combination / therapeutic use
  • Endophthalmitis / drug therapy
  • Endophthalmitis / epidemiology*
  • Endophthalmitis / microbiology*
  • Eye Infections, Bacterial / drug therapy
  • Eye Infections, Bacterial / epidemiology*
  • Eye Infections, Bacterial / microbiology*
  • Female
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Postoperative Complications*
  • Proteus mirabilis / isolation & purification
  • Pseudomonas aeruginosa / isolation & purification
  • Retrospective Studies
  • Staphylococcus aureus / isolation & purification
  • Staphylococcus epidermidis / isolation & purification
  • Treatment Outcome
  • Visual Acuity / physiology*
  • Vitrectomy / adverse effects*
  • Vitreous Body / microbiology

Substances

  • Anti-Bacterial Agents